BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 29340030)

  • 1. Increased efficacy of metformin corresponds to differential metabolic effects in the ovarian tumors from obese
    Han J; Wysham WZ; Zhong Y; Guo H; Zhang L; Malloy KM; Dickens HK; Huh G; Lee D; Makowski L; Zhou C; Bae-Jump VL
    Oncotarget; 2017 Dec; 8(67):110965-110982. PubMed ID: 29340030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of obesity-driven aggressiveness of endometrial cancer by metformin.
    Guo H; Kong W; Zhang L; Han J; Clark LH; Yin Y; Fang Z; Sun W; Wang J; Gilliam TP; Lee D; Makowski L; Zhou C; Bae-Jump VL
    Am J Cancer Res; 2019; 9(10):2170-2193. PubMed ID: 31720081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NT1014, a novel biguanide, inhibits ovarian cancer growth in vitro and in vivo.
    Zhang L; Han J; Jackson AL; Clark LN; Kilgore J; Guo H; Livingston N; Batchelor K; Yin Y; Gilliam TP; Gehrig PA; Sheng X; Zhou C; Bae-Jump VL
    J Hematol Oncol; 2016 Sep; 9(1):91. PubMed ID: 27655410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effects of NT-1044, a Novel AMPK Activator, on Endometrial Cancer Cell Proliferation, Apoptosis, Cell Stress and
    Roque DR; Zhang L; Wysham WZ; Han J; Sun W; Yin Y; Livingston JN; Batchelor KW; Zhou C; Bae-Jump VL
    Front Oncol; 2021; 11():690435. PubMed ID: 34422646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancer.
    Suri A; Sheng X; Schuler KM; Zhong Y; Han X; Jones HM; Gehrig PA; Zhou C; Bae-Jump VL
    Oncotarget; 2016 Jun; 7(26):39582-39594. PubMed ID: 27074576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenformin has anti-tumorigenic effects in human ovarian cancer cells and in an orthotopic mouse model of serous ovarian cancer.
    Jackson AL; Sun W; Kilgore J; Guo H; Fang Z; Yin Y; Jones HM; Gilliam TP; Zhou C; Bae-Jump VL
    Oncotarget; 2017 Nov; 8(59):100113-100127. PubMed ID: 29245964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting dopamine receptor D2 as a novel therapeutic strategy in endometrial cancer.
    Pierce SR; Fang Z; Yin Y; West L; Asher M; Hao T; Zhang X; Tucker K; Staley A; Fan Y; Sun W; Moore DT; Xu C; Tsai YH; Parker J; Prabhu VV; Allen JE; Lee D; Zhou C; Bae-Jump V
    J Exp Clin Cancer Res; 2021 Feb; 40(1):61. PubMed ID: 33557912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity increases tumor aggressiveness in a genetically engineered mouse model of serous ovarian cancer.
    Makowski L; Zhou C; Zhong Y; Kuan PF; Fan C; Sampey BP; Difurio M; Bae-Jump VL
    Gynecol Oncol; 2014 Apr; 133(1):90-7. PubMed ID: 24680597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Everolimus exhibits anti-tumorigenic activity in obesity-induced ovarian cancer.
    Guo H; Zhong Y; Jackson AL; Clark LH; Kilgore J; Zhang L; Han J; Sheng X; Gilliam TP; Gehrig PA; Zhou C; Bae-Jump VL
    Oncotarget; 2016 Apr; 7(15):20338-56. PubMed ID: 26959121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Tumor and Anti-Invasive Effects of ONC201 on Ovarian Cancer Cells and a Transgenic Mouse Model of Serous Ovarian Cancer.
    Fan Y; Wang J; Fang Z; Pierce SR; West L; Staley A; Tucker K; Yin Y; Sun W; Kong W; Prabhu V; Allen JE; Zhou C; Bae-Jump VL
    Front Oncol; 2022; 12():789450. PubMed ID: 35372029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly potent dopamine receptor D2 antagonist ONC206 demonstrates anti-tumorigenic activity in endometrial cancer.
    Staley A; Tucker K; Yin Y; Zhang X; Fan Y; Zhang Y; Fang Z; Sun W; Suo H; Zhao X; Zhao Z; Prabhu VV; Allen JE; Zhou C; Bae-Jump VL
    Am J Cancer Res; 2021; 11(11):5374-5387. PubMed ID: 34873466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asparagus officinalis Exhibits Anti-Tumorigenic and Anti-Metastatic Effects in Ovarian Cancer.
    Xu G; Kong W; Fang Z; Fan Y; Yin Y; Sullivan SA; Tran AQ; Clark LH; Sun W; Hao T; Zhao L; Zhou C; Bae-Jump VL
    Front Oncol; 2021; 11():688461. PubMed ID: 34336674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docosahexaenoic acid (DHA), an omega-3 fatty acid, inhibits tumor growth and metastatic potential of ovarian cancer.
    West L; Yin Y; Pierce SR; Fang Z; Fan Y; Sun W; Tucker K; Staley A; Zhou C; Bae-Jump V
    Am J Cancer Res; 2020; 10(12):4450-4463. PubMed ID: 33415010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner.
    Rattan R; Giri S; Hartmann LC; Shridhar V
    J Cell Mol Med; 2011 Jan; 15(1):166-78. PubMed ID: 19874425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TallyHO obese female mice experience poor reproductive outcomes and abnormal blastocyst metabolism that is reversed by metformin.
    Louden ED; Luzzo KM; Jimenez PT; Chi T; Chi M; Moley KH
    Reprod Fertil Dev; 2014 Dec; 27(1):31-9. PubMed ID: 25472042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ONC206 has anti-tumorigenic effects in human ovarian cancer cells and in a transgenic mouse model of high-grade serous ovarian cancer.
    Tucker K; Yin Y; Staley SA; Zhao Z; Fang Z; Fan Y; Zhang X; Suo H; Sun W; Prabhu VV; Allen JE; Zhou C; Bae-Jump VL
    Am J Cancer Res; 2022; 12(2):521-536. PubMed ID: 35261784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer.
    Schuler KM; Rambally BS; DiFurio MJ; Sampey BP; Gehrig PA; Makowski L; Bae-Jump VL
    Cancer Med; 2015 Feb; 4(2):161-73. PubMed ID: 25417601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of obesity and 10 weeks metformin treatment on liver steatosis.
    Hakkak R; Rose S; Spray B; Kozaczek M; Korourian S
    Biomed Rep; 2021 Jun; 14(6):49. PubMed ID: 33859820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways.
    Wang Y; Xu W; Yan Z; Zhao W; Mi J; Li J; Yan H
    J Exp Clin Cancer Res; 2018 Mar; 37(1):63. PubMed ID: 29554968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells.
    Li C; Liu VW; Chan DW; Yao KM; Ngan HY
    Int J Gynecol Cancer; 2012 Jan; 22(1):15-22. PubMed ID: 22080879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.